Inhibition of protective immunity against Staphylococcus aureus infection by MHC-restricted immunodominance is overcome by vaccination

scientific article published on 01 April 2020

Inhibition of protective immunity against Staphylococcus aureus infection by MHC-restricted immunodominance is overcome by vaccination is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1126/SCIADV.AAW7713
P932PMC publication ID7112766
P698PubMed publication ID32270029

P50authorAlessandro SetteQ28324161
Daniela WeiskopfQ29382149
Anita S ChongQ56931262
Maria-Luisa AlegreQ63522408
Youhui SiQ80534875
Qiaomu TianQ91745137
Christopher P MontgomeryQ91745140
P2093author name stringFan Zhao
Pavani Beesetty
Zhaotao Li
P2860cites workCommunity-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicQ24614464
Vaccine protection against Staphylococcus aureus pneumoniaQ24650703
The importance of immune gene variability (MHC) in evolutionary ecology and conservationQ24816496
Memory T follicular helper CD4 T cellsQ26829047
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionQ27860958
Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumoniaQ28260215
Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophilsQ33523802
Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infectionQ33769704
Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse modelQ34154110
Targeting Staphylococcus aureus α-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue infectionsQ34396053
The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptorsQ34495209
Staphylococcus aureus infection induces protein A-mediated immune evasion in humans.Q34533083
Identifying protective antigens of Staphylococcus aureus, a pathogen that suppresses host immune responsesQ35225082
High Staphylococcus aureus colonization prevalence among patients with skin and soft tissue infections and controls in an urban emergency departmentQ35331205
Staphylococcus aureus skin infection recurrences among household members: an examination of host, behavioral, and pathogen-level predictorsQ35473688
Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection.Q35833250
Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized studyQ35887127
Genetic requirement for ADAM10 in severe Staphylococcus aureus skin infectionQ35888551
Proteomic Identification of saeRS-Dependent Targets Critical for Protective Humoral Immunity against Staphylococcus aureus Skin InfectionQ35947359
Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude.Q36383089
An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitroQ36433369
Tracking epitope-specific T cells.Q36454999
CCR5 is a receptor for Staphylococcus aureus leukotoxin ED.Q36508062
A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection.Q36811244
Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1.Q36967664
Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection.Q37422943
Protective immunity against recurrent Staphylococcus aureus skin infection requires antibody and interleukin-17A.Q37713405
Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trialQ38453557
The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors.Q39416905
Immunodominance in T lymphocyte recognitionQ39514306
Determinant Selection and Macrophage Function in Genetic Control of the Immune ResponseQ39558237
Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody captureQ39849181
Impact of Staphylococcus aureus USA300 Colonization and Skin Infections on Systemic Immune Responses in HumansQ40617495
The Fall of a Dogma? Unexpected High T-Cell Memory Response to Staphylococcus aureus in HumansQ41451687
Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing riskQ41714469
O-Acetylation of Peptidoglycan Limits Helper T Cell Priming and Permits Staphylococcus aureus Reinfection.Q41994684
Clonally expanded γδ T cells protect against Staphylococcus aureus skin reinfectionQ50199724
Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus.Q51835878
Two complementary methods for predicting peptides binding major histocompatibility complex molecules.Q52266980
Antigen-specific interaction between T and B cellsQ59063745
On the complexity of selfQ59092662
Models matter: the search for an effective Staphylococcus aureus vaccineQ59806683
The effect of haptens on protein-carrier immunogenicityQ87415852
P433issue14
P921main subjectStaphylococcus aureusQ188121
P304page(s)eaaw7713
P577publication date2020-04-01
P1433published inScience AdvancesQ19881044
P1476titleInhibition of protective immunity against Staphylococcus aureus infection by MHC-restricted immunodominance is overcome by vaccination
P478volume6

Search more.